Normal physiology and HIV pathophysiology of human T-cell dynamics

Por Richman, Douglas D.
Publicado em 2000

Introduction: challenges to finding a cure for HIV infection

Por Richman, Douglas D.
Publicado em 2011

Antiviral Drug Discovery To Address the COVID-19 Pandemic

Por Richman, Douglas D.
Publicado no mBio (2020)

COVID-19 vaccines: implementation, limitations and opportunities

Por Richman, Douglas D.
Publicado no Glob Health Med (2021)

Minority Variants of Drug-Resistant HIV

Por Gianella, Sara, Richman, Douglas D.
Publicado em 2010

Measuring the latent reservoir in vivo

Por Massanella, Marta, Richman, Douglas D.
Publicado no J Clin Invest (2016)

Antiviral Therapy

Por Richman, Douglas D., Nathanson, Neal
Publicado no Viral Pathogenesis (2016)

New assays for monitoring residual HIV burden in effectively treated individuals

Por Strain, Matthew C., Richman, Douglas D.
Publicado em 2013

Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review

Por Stadeli, Kathryn M, Richman, Douglas D
Publicado no Antivir Ther (2012)

Editorial overview: Antivirals and resistance: Advances and challenges ahead

Por Menéndez-Arias, Luis, Richman, Douglas D
Publicado no Curr Opin Virol (2014)

CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines

Por Kornbluth, Richard S., Kee, Kristin, Richman, Douglas D.
Publicado em 1998

Molecular and Cellular Analysis of Human Immunodeficiency Virus-Induced Apoptosis in Lymphoblastoid T-Cell-Line-Expressing Wild-Type and Mutated CD4 Receptors

Por Moutouh, Laure, Estaquier, Jérôme, Richman, Douglas D., Corbeil, Jacques
Publicado em 1998

Preferential replication of HIV-1 in the CD45RO memory cell subset of primary CD4 lymphocytes in vitro

Por Spina, Celsa A., Prince, Harry E., Richman, Douglas D.
Publicado em 2000

Rapid evolution of the neutralizing antibody response to HIV type 1 infection

Por Richman, Douglas D., Wrin, Terri, Little, Susan J., Petropoulos, Christos J.
Publicado em 2003

Use of temperature-sensitive mutants of influenza A virus as live virus vaccine strains. Evaluation in laboratory animals, adults and children

Por Murphy, Brian R., Richman, Douglas D., Spring, Susan B., Chanock, Robert M.
Publicado em 1976

A Synthetic Bivalent Ligand of CXCR4 Inhibits HIV Infection

Por Xu, Yan, Duggineni, Srinivas, Espitia, Stephen, Richman, Douglas D., An, Jing, Huang, Ziwei
Publicado em 2013

Antibody Response to Achromobacter xylosoxidans during HIV Infection Is Associated with Lower CD4 Levels and Increased Lymphocyte Activation

Por Tatro, Erick T., Purnajo, Intan, Richman, Douglas D., Smith, Davey M., Gianella, Sara
Publicado em 2014

Evaluation of a Highly Sensitive Qualitative Human Immunodeficiency Virus Type 1 (HIV-1) RNA Assay for Detection of HIV-1 Suppression

Por Nugent, C. Thomas, Nodelman, Vladislav, Giachetti, Cristina, Richman, Douglas D., Looney, David J.
Publicado em 2009

Quantification of Total and 2-LTR (Long terminal repeat) HIV DNA, HIV RNA and Herpesvirus DNA in PBMCs

Por Massanella, Marta, Gianella, Sara, Lada, Steven M., Richman, Douglas D., Strain, Matthew C.
Publicado no Bio Protoc (2015)

The Efficiency of Single Genome Amplification and Sequencing is Improved by Quantitation and Use of a Bioinformatics Tool

Por Butler, David M., Pacold, Mary E., Jordan, Parris S., Richman, Douglas D., Smith, Davey M.
Publicado em 2009